Glucose B. Braun (Glucose Monohydrate)

Glucose B. Braun is indicated for several clinical situations where rapid provision of glucose and fluid balance is required.

• Treatment of hypoglycemia in patients unable to receive oral glucose.
• Component of parenteral nutrition regimens to supply calories.
• Fluid and electrolyte replacement during dehydration or postoperative care.
• Prevention of intra‑operative hypoglycemia in surgical patients.
• Support for patients with metabolic disorders requiring controlled glucose infusion.

When administered intravenously, Glucose B. Braun may be associated with a range of observed effects. Most reactions are mild, dose‑related, and resolve after the infusion is completed.

Common

• Mild hyperglycemia that resolves without intervention.
• Local irritation or pain at the injection site.
• Nausea or transient vomiting.
• Fluid overload in patients receiving large volumes.
• Transient headache or dizziness.
• Mild increase in serum triglycerides.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Electrolyte disturbances such as hyponatremia.
• Hypersensitivity reactions including rash, urticaria, or anaphylaxis.
• Cardiac arrhythmias secondary to electrolyte shifts.
• Acute pulmonary edema in patients with compromised cardiac function.
• Renal impairment due to osmotic diuresis.

Glucose B. Braun should be used with attention to patient‑specific factors and clinical conditions that may modify its safety profile.

• Assess blood glucose levels before and during infusion to avoid excessive hyperglycemia.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Use caution in individuals with known hypersensitivity to glucose solutions or excipients.
• Monitor electrolyte concentrations, especially sodium and potassium, during prolonged therapy.
• Avoid concurrent administration with high‑dose dextrose-containing products unless clinically justified.
• Ensure aseptic technique to reduce risk of catheter‑related infections.

Glucose B. Braun may interact with other intravenous therapies; awareness of potential interactions helps maintain safe infusion practices.

Avoid

• Co‑administration with other high‑concentration dextrose solutions without adjusting total carbohydrate load.
• Simultaneous infusion of potassium chloride in concentrations exceeding recommended limits, which can precipitate.
• Mixing with calcium-containing solutions, which can cause precipitation.

Use with caution

• Concurrent use of insulin infusions; glucose may counteract insulin’s glucose‑lowering effect.
• Administration with loop diuretics, as rapid fluid shifts can affect electrolyte balance.
• Combination with sodium bicarbonate solutions, which may alter serum pH and glucose metabolism.
• Concurrent administration of beta‑blockers, which may mask signs of hypoglycemia.